Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.075 USD | +1.25% | +6.70% | -6.20% |
May. 20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
May. 06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 256M | |
+7.83% | 115B | |
+13.11% | 107B | |
-12.99% | 22.31B | |
-3.99% | 21.6B | |
-6.20% | 18.23B | |
-39.93% | 17.62B | |
+7.09% | 14.26B | |
+32.65% | 12.37B | |
-28.24% | 8.28B |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Morgan Stanley Adjusts Price Target on Foghorn Therapeutics to $10 From $13, Maintains Equal-Weight Rating